Abstract
A concise and enantioselective total synthesis of the Veratrum alkaloid cyclopamine is disclosed. This highly convergent synthesis with a 16-step longest linear sequence (LLS) was enabled by a de novo synthesis of the trans-6,5 hetero-bicycle via a strain-inducing halocyclization process, a key Tsuji-Trost cyclization to construct the fully substituted, spirocyclic THF motif with exquisite diastereocontrol, and a late-stage ring-closing metathesis (RCM) reaction to forge the central tetrasubstituted olefin.
Graphical Abstract

Cyclopamine (1), first isolated from Veratrum californicum (California corn lily),1 is a notable member of the Veratrum alkaloid family (Figure 1A).2 It is known ex post facto for inducing the cyclopia birth defect in sheep, where the affected new-born lambs only had one eye and were reminiscent of the cyclops from Greek mythology.3 Studies from Beachy et al. revealed that cyclopamine is a potent inhibitor of the highly conserved hedgehog signaling pathway, which is critical for the correct differentiation and symmetry development of embryos.4 Despite its known decomposition pathway leading to veratramine (3) or potentially other byproducts under acidic conditions,5 cyclopamine has been recognized as a promising lead compound for anti-cancer agents and numerous medicinal analogs have been reported to date, most notably the semi-synthetically prepared saridegib (4).6
Figure 1.
Cyclopamine (1): (A) related family members, medicinal analogs, and previous syntheses; (B) retrosynthetic analysis in this work.
The intricate structures of Veratrum alkaloids have piqued the interest of synthetic chemists for years.7 With respect to cyclopamine, the rare C-nor-D-homo steroid skeleton is further complicated by the fully substituted, spirocyclic THF motif, the unique trans-6,5 EF ring system, and the central tetrasubstituted olefin, all of which posed unique challenges to its synthesis. A pioneering synthesis of the closely related jervine (2) by the Masamune group involves an 18-step sequence starting from the advanced intermediate 6, which in turn must be prepared in 25 steps from Hagemann’s ester or obtained from degradation of hecogenin.7a More recently in 2009, Giannis et al. disclosed an elegant semi-synthesis of cyclopamine in 20 steps from dehydroepiandrosterone (5), featuring a biomimetic 1,2-skeletal rearrangement to construct the C-nor-D-homo steroid scaffold.7h Multiple progress-towards studies of jervine or cyclopamine have also been reported to date.8 This Communication discloses a convergent and enantioselective total synthesis of 1 with a 16-step longest linear sequence (LLS).
The final retrosynthetic depiction shown in Figure 1B benefitted from the learnings of multiple generations of unsuccessful routes, most of which were based on the convergent union of ABC and EF fragments followed by D-ring formation post-coupling (see SI for details). Learnings from those studies led to the current approach wherein a fully formed ABC tricycle (Fragment A, 7) was coupled to an EF bicycle progenitor (Fragment B, 8) via a diastereoselective 1,2-addition. The late-stage formation of the D/E ring systems hinged on a Tsuji-Trost cyclization to forge the THF ring and an RCM reaction to build the central tetrasubstituted olefin. 7 and 8 could in turn be prepared from readily available building blocks such as (S)-Wieland Miescher ketone (9) and 2-siloxyfuran 10.
The synthesis of 7 (Scheme 1A) commenced from the decalin 11, the TBS variant of which was previously prepared in 4 steps from (S)-Wieland-Miescher ketone (9).8k Unfortunately, our attempts to directly adapt this procedure for the preparation of Bn-protected 11 were unsuccessful (see SI) and eventually required 2 additional steps to exchange the protecting group, resulting in a non-ideal 6 step sequence. An alternative 3-step protocol amenable to gram scale operations was thus developed involving enone isomerization/reduction of acetal protected 9 (see SI for details). A cyclopentenone annulation sequence was subsequently carried out using the known phosphonate reagent 129: the lithium enolate of 11 was first alkylated with 12 to afford intermediate 13 as a 1:1 mixture of C9 epimers (after hydrolysis of the enol ether), which upon treatment with Cs2CO3 underwent an intramolecular Horner-Wadsworth-Emmons reaction to forge the cyclopentenone motif with concomitant equilibration to a 9:1 mixture of C9 epimers favoring the desired diastereomer, as confirmed by X-ray crystallographic analysis. Further enrichment of 14 to >20:1 dr was achieved after a single round of recrystallization from hexanes/DCM (ca. 10:1). With gram quantities of 14 at hand, a second enolate alkylation at C13 with tert-butyl bromoacetate proceeded smoothly to yield 15 as a single diastereomer. The conjugate reduction of enone 15 required judicious choice of reagents (see SI for the full optimization table). Whereas Stryker’s reagent and SmI2 gave no reaction and Shenvi’s HAT reduction conditions10 resulted in decomposition, a reactive CuH species reported by Lipshutz and coworkers11 proved to be the optimal choice, furnishing the desired 1,4-reduction product 16 in 86% yield as a single diastereomer without any undesired 1,2-reduction. The excellent diastereoselectivity observed could be rationalized by the angular methyl group blocking CuH approach from the top face of 15. Ketone 16 was ultimately transformed to the 1,2-addition precursor 7 by Wittig olefination, DIBAL-H reduction of the tBu ester, and finally an Appel reaction to convert the resulting primary alcohol to iodide.
Scheme 1. Synthesis of fragments A (7) and B (8).a.
a For detailed reagents and conditions, see Supporting Information.
Multiple strategies (see SI) to access fragment B (8) were evaluated via a structure such as lactone 20 (Scheme 1B). Similar molecules have been prepared in the past through labor-intensive chiral pool strategies. For instance, a derivative of 20 bearing a Cbz instead of a benzenesulfonyl (Bs) group was previously accessed in either 9 steps8c or 6 steps8h from (S)-citronellal, with 2 additional steps required for protecting group exchange as the Bs group has proven to be essential for late-stage manipulations (see SI for discussion). A concise 4-step route to 20 was thus developed through an unusual sequence relying on the C5-selective asymmetric allylic alkylation (AAA) of siloxyfuran 10 as reported by Arseniyadis et al.12 This key precedent was improved for the synthesis of γ-butenolide 17 through the addition of NH4OAc (as per suggested by the Arseniyadis group in our correspondence), which further boosted reaction efficiency and regioselectivity (favoring C5 allylation over C3), delivering 17 in 75% isolated yield and 97% ee (see SI for details). Subsequent aza-Michael addition to 17 required substantial screening (see SI) that eventually led to the identification of BsNHOBn (N-benzenesulfonyl-O-benzylhydroxylamine) as the optimal nucleophile. X-ray analysis confirmed that addition occurred exclusively trans to the existing γ substituent on the butenolide. In its fully optimized form, this reaction involved directly treating the aza-Michael adduct with Zn0/NH4Cl in the same reaction vessel to effect N-O bond cleavage and furnish the sulfonamide 18 as a single diastereomer in 71% isolated yield. Racemization of 18 (71% ee) was observed but could be rectified by a single round of recrystallization from DCM/Et2O (1:1), which restored its enantiopurity (>97% ee, 50% yield overall). With gram quantities of 18 at hand, the key halocyclization step to construct the strained trans-6,5 EF bicycle was investigated. Due to the extreme strain that would be incurred through a 5-exo-trig cyclization to deliver a trans-5,5 ring system, it was rationalized that an unusual 6-endo-trig cyclization would be preferred. After the initial hit with NIS/K2CO3 verified this hypothesis, further screening was performed (see SI for details) that eventually led to the most reproducible and scalable protocol with KOtBu/I2. In its fully optimized form, the halocyclization step furnished the tertiary iodide 19 in 51% yield as an inconsequential 10:1 mixture of diastereomers (favoring the axial iodide, see SI), which was then subjected to a tin hydride-mediated dehalogenation reaction to afford the desired lactone 20 in 71% yield as a single diastereomer. This stereochemical outcome could be rationalized as a combination of stereoelectronics (axial iodide is more susceptible to abstraction), thermodynamic preference (methyl group prefers to be equatorial), and steric bulk of the benzenesulfonyl group (which disfavors hydride approach from top face of the tertiary radical). It is worth noting that the ring-opening side product 18 was consistently observed on larger scale (>100 mg) and could be isolated in 21% yield. Attempts to suppress this process by running the reaction at ambient temperature instead of 100 °C (see SI) surprisingly exacerbated ring-opening (20:18 = 1:1, vs. 3:1 with AIBN at 100 °C). Besides this piece of evidence, we also observed that 1) the halocyclization reaction exhibited certain degrees of reversibility over prolonged reaction times (see SI), and 2) addition of TEMPO to the halocyclization reaction inhibited product formation. These clues led us to speculate that the halocylization might proceed through a one-electron pathway involving formation and homolysis of an N-I species (see SI). Methylation of 20 by enolate alkylation proceeded smoothly to deliver the key lactone 21 as a single diastereomer, the structure of which was confirmed by X-ray analysis. The diastereoselectivity observed was in line with Taber’s report8h on a similar scaffold and could be attributed to the axial β-H at the ring junction blocking electrophile approach from the top face of 20. Finally, addition of isopropenyllithium to lactone 21 yielded a hemiketal that was in equilibrium with the open-chain hydroxyketone, the secondary alcohol of which could be TES protected in the same pot to furnish enone 8 in 65% yield.
With both fragments (7 and 8) in hand, the endgame sequence (Scheme 2) commenced with union of the two fragments by 1,2-addition, wherein the primary iodide 7 first underwent lithium halogen exchange with tBuLi, and then the resulting alkyllithium species added into enone 8. Addition of LaCl3•2LiCl proved to be crucial (see SI for additive screening) for the exclusive 1,2-regioselectivity observed in this reaction,13 yielding tertiary alcohol 22 as a single diastereomer (confirmed by X-ray) possibly due to Felkin-Anh selectivity. This success set the stage for the final D/E ring double cyclization sequence, which entailed formation of the E ring through an alkoxide Tsuji-Trost cyclization followed by formation of the D ring by ring-closing metathesis (RCM). The challenging Tsuji-Trost cyclization turned out to be an immense undertaking that required considerable optimization (see SI). To our delight, Boc carbonate 23 (prepared from 22 in two steps) emerged as the singularly successful substrate, delivering the desired THF-containing RCM precursor 24 in 73% yield with perfect net stereoretention from tertiary alcohol 22. This diastereochemical outcome was in line with previous observations in similar THF-forming Tsuji-Trost cyclizations.14 The RCM reaction to form the tetrasubstituted olefin, which was the final hurdle in this synthesis, was initially met with expected difficulties (see SI for details): conventional metathesis catalysts such as Hoveyda-Grubbs 2nd generation catalyst (Ru-1) gave low conversions even at elevated temperatures, and the less sterically encumbering o-tolyl variant Ru-2 only led to slightly improved results. Fortunately, the indenylidene catalyst Ru-3 was reported to be an extremely effective metathesis catalyst for sterically demanding substrates.15 Indeed, a significant improvement in yield was observed with Ru-3, which, when combined with perfluorotoluene as solvent, 15b led to the optimal condition that afforded bis-protected cyclopamine 25 in 85% yield, the structure of which was confirmed by X-ray analysis. The prior approach of Giannis necessitated two distinct reductive deprotection conditions to excise Bn and sulfonamide groups in 79% overall yield.7h Instead, removal of both groups could be accomplished with freshly prepared LiDBB16, yielding (−)-cyclopamine in 78% yield. It is worth noting that when acquiring NMR data for cyclopamine in CD2CL2, a solvent that was used in multiple previous reports, we observed that concentration of the sample had a significant impact on the chemical shifts of cyclopamine’s 1H and 13C spectra (see SI for discussion).
Scheme 2. Total synthesis of (−)-cyclopamine (1).a.
a For detailed reagents and conditions, see Supporting Information.
To conclude, a convergent total synthesis of (−)-cyclopamine (1) was achieved with a 16-step LLS (1.4% overall yield, 61% ideality,17 see SI for calculation) from (S)-Wieland-Miescher ketone. Unlike the semi-synthetic routes which predate this disclosure, the strategy outlined herein should be amenable to exploring deep-seated structural modifications for further SAR studies of this promising class of natural products. Key areas for improvement for which there are methodological gaps include a more direct conversion of 18 to 20 (see SI for discussion) and a more concise fragment coupling that can minimize protecting group manipulations. That said, notable features of this synthesis include rapid stereocontrolled access to similarly sized coupling fragments, namely the streamlined ABC-ring synthesis through annulation/CuH reduction and an unusually concise furan-based access to the key EF ring system via AAA/aza-Michael/halocyclization. Furthermore, the exquisite stereocontrol exhibited in the fragment coupling/strained THF ring formation prior to the high-yielding RCM cyclization represents a bold yet effective means of accessing 1.
Supplementary Material
ACKNOWLEDGMENT
Financial support for this work was provided by LEO Pharma and NIH (GM-118176). M.S. acknowledges the European Union’s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie grant agreement No 10102337 (H2020-MSCA-IF-2020-GF-10102337-ElectroPheX) for financial support. B. N. acknowledges the DAAD scholarship for financial support. Authors are grateful to Dr. Dee-Hua Huang, Dr. Laura Pasternack, and Dr. Gerard Kroon (Scripps Research) for assistance with spectroscopy; to Dr. Jason Chen, Brittany Sanchez, Quynh Nguyen, and Jason Lee (Scripps Research ASF) for assistance with chiral SFC and HRMS analysis; to Elizabeth Billings (The Center for Metabolomics and Mass Spectrometry, Scripps Research) for HRMS analysis; and to Dr. Arnold Rheingold, Dr. Milan Gembicky, and Dr. Jake Bailey (UCSD) for X-Ray crystallographic analysis. We thank the Arseniyadis group for correspondence and suggestions regarding optimization of the AAA reaction. We thank Dr. Pengfei Hu (now assistant professor at Westlake University) for experimental assistance with early-stage explorations of this project.
Footnotes
Supporting Information
The Supporting Information is available free of charge on the ACS Publications website.
Detailed experimental procedures and analytical data (PDF)
REFERENCES
- 1).Keeler RF, Teratogenic compounds of veratrum californicum (durand)–IV. First isolation of veratramine and alkaloid Q and A reliable method for isolation of cyclopamine. Phytochemistry 1968, 7, 303–306. [Google Scholar]
- 2).(a) For reviews of cyclopamine and/or other Veratrum alkaloids, see: Li H-J; Jiang Y; Li P, Chemistry, bioactivity and geographical diversity of steroidal alkaloids from the Liliaceae family. Nat. Prod. Rep 2006, 23, 735–752. [DOI] [PubMed] [Google Scholar]; (b) Heretsch P; Giannis A The Veratrum and Solanum Alkaloids. In The Alkaloids: Chemistry and Biology; Elsevier, 2015; Vol. 74, pp 201–232. [DOI] [PubMed] [Google Scholar]; (c) Dirks ML; Seale JT; Collins JM; McDougal OM Review: Veratrum californicum Alkaloids. Molecules 2021, 26, 5934. [DOI] [PMC free article] [PubMed] [Google Scholar]; (d) Heretsch P; Tzagkaroulaki L; Giannis A, Cyclopamine and Hedgehog Signaling: Chemistry, Biology, Medical Perspectives. Angew. Chem. Int. Ed 2010, 49, 3418–3427. [DOI] [PubMed] [Google Scholar]; (e) Lee ST; Welch KD; Panter KE; Gardner DR; Garrossian M; Chang C-WT, Cyclopamine: From Cyclops Lambs to Cancer Treatment. J. Agric. Food Chem 2014, 62, 7355–7362. [DOI] [PubMed] [Google Scholar]; (f) Chen JK, I only have eye for ewe: the discovery of cyclopamine and development of Hedgehog pathway-targeting drugs. Nat. Prod. Rep 2016, 33, 595–601. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3).(a) Keeler RF, Toxic and teratogenic alkaloids of western range plants. J. Agric. Food Chem 1969, 17, 473–482. [Google Scholar]; (b) James LF; Panter KE; Gaffield W; Molyneux RJ, Biomedical Applications of Poisonous Plant Research. J. Agric. Food Chem 2004, 52, 3211–3230. [DOI] [PubMed] [Google Scholar]
- 4).Cooper MK; Porter JA; Young KE; Beachy PA, Teratogen-Mediated Inhibition of Target Tissue Response to Shh Signaling. Science 1998, 280, 1603–1607. [DOI] [PubMed] [Google Scholar]
- 5).(a) There are disagreements in literature regarding the exact acid decomposition products of cyclopamine, the details of which are beyond the scope of this Communication. See: Keeler RF, Teratogenic compounds of veratrum californicum (durand) - VI: The structure of cyclopamine. Phytochemistry 1969, 8, 223–225. [Google Scholar]; (b) Wilson SR; Strand MF; Krapp A; Rise F; Petersen D; Krauss S, Hedgehog antagonist cyclopamine isomerizes to less potent forms when acidified. J. Pharm. Biomed. Anal 2010, 52, 707–713. [DOI] [PubMed] [Google Scholar]
- 6).(a) Tremblay MR; Lescarbeau A; Grogan MJ; Tan E; Lin G; Austad BC; Yu L-C; Behnke ML; Nair SJ; Hagel M; White K; Conley J; Manna JD; Alvarez-Diez TM; Hoyt J; Woodward CN; Sydor JR; Pink M; MacDougall J; Campbell MJ; Cushing J; Ferguson J; Curtis MS; McGovern K; Read MA; Palombella VJ; Adams J; Castro AC, Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926). J. Med. Chem 2009, 52, 4400–4418. [DOI] [PubMed] [Google Scholar]; (b) Martinot TA; Austad BC; Côté A; Depew KM; Genov D; Grenier L; Helble J; Lescarbeau A; Nair S; Trudeau M; White P; Yu L-C, A Design of Experiments Approach to a Robust Final Deprotection and Reactive Crystallization of IPI-926, A Novel Hedgehog Pathway Inhibitor. Org. Process Res. Dev 2015, 19, 1693–1702. [Google Scholar]; (c) Austad BC; Hague AB; White P; Peluso S; Nair SJ; Depew KM; Grogan MJ; Charette AB; Yu L-C; Lory CD; Grenier L; Lescarbeau A; Lane BS; Lombardy R; Behnke ML; Koney N; Porter JR; Campbell MJ; Shaffer J; Xiong J; Helble JC; Foley MA; Adams J; Castro AC; Tremblay MR, Development of a Multi Kilogram-Scale, Tandem Cyclopropanation Ring-Expansion Reaction en Route to Hedgehog Antagonist IPI-926. Org. Process Res. Dev 2016, 20, 786–798. [Google Scholar]
- 7).(a) For past syntheses of Veratrum alkaloids, see: Masamune T; Takasugi M; Murai A; Kobayashi K C-nor-D-homo steroids and related alkaloids. IX. Synthesis of jervine and related alkaloids. J. Am. Chem. Soc 1967, 89, 4521–4523. [Google Scholar]; (b) Johnson WS; DeJongh HAP; Coverdale CE; Scott JW; Burckhardt U The synthesis of veratramine. J. Am. Chem. Soc 1967, 89, 4523–4524. [Google Scholar]; (c) Kutney JP; Cable J; Gladstone WAF; Hanssen HW; Torupka EJ; Warnock WDC Total synthesis of steroidal derivatives. V. The total synthesis of veratrum alkaloids. 1. Verarine. J. Am. Chem. Soc 1968, 90, 5332–5334. [DOI] [PubMed] [Google Scholar]; (d) Kutney JP; By A; Cable J; Gladstone WAF; Inaba T; Leong SY; Roller P; Torupka EJ; Warnock WDC Synthetic Studies in the Veratrum Alkaloid Series. I. Introduction and the Total Synthesis of Appropriate C-nor-D-homo Steroid Derivatives. Can. J. Chem 1975, 53, 1775–1795. [Google Scholar]; (e) Kutney JP; Cable J; Gladstone WAF; Hanssen HW; Nair GV; Torupka EJ; Warnock WDC Synthetic Studies in the Veratrum Alkaloid Series. II. The Total Synthesis of Verarine, Veratramine, Jervine, and Veratrobasine. Can. J. Chem 1975, 53, 1796–1817. [Google Scholar]; (f) Kutney JP; Fortes CC; Honda T; Murakami Y; Preston A; Ueda Y Synthetic Studies in the Veratrum Alkaloid Series. The Total Synthesis of Verticine. J. Am. Chem. Soc 1977, 99, 964–966. [DOI] [PubMed] [Google Scholar]; (g) Kutney JP; Brookes RW; Fortes CC; Murakami Y; Preston A; Ueda Y Synthetic Studies in the Veratrum Alkaloid Series. The Total Synthesis of C18-functionalized C-nor-D-homo Steroid Derivatives – Valuable Intermediates in the Total Synthesis of Veratrum Alkaloids. J. Am. Chem. Soc 1977, 99, 963–964. [DOI] [PubMed] [Google Scholar]; (h) Giannis A; Heretsch P; Sarli V; Stδßel A, Synthesis of Cyclopamine Using a Biomimetic and Diastereoselective Approach. Angew. Chem. Int. Ed 2009, 48, 7911–7914. [DOI] [PubMed] [Google Scholar]; (i) Cassaidy KJ; Rawal VH, Enantioselective Total Synthesis of (+)-Heilonine. J. Am. Chem. Soc 2021, 143, 16394–16400. [DOI] [PMC free article] [PubMed] [Google Scholar]; (j) Guo Y; Lu J-T; Fang R; Jiao Y; Liu J; Luo T, Enantioselective Total Synthesis of (−)-Zygadenine. J. Am. Chem. Soc 2023, Article ASAP. DOI: 10.1021/jacs.3c08039 (accessed 2023-09-13). [DOI] [PubMed] [Google Scholar]
- 8).(a) Brown E; Lebreton J A total synthesis of C-nor-D-homo steroids of the A→B→ C→D type, involving a reductive alkylation step for construction of the d-ring. Tetrahedron Lett. 1986, 27, 2595–2598. [Google Scholar]; (b) Winkler JD; Isaacs A; Holderbaum L; Tatard V; Dahmane N, Design and Synthesis of Inhibitors of Hedgehog Signaling Based on the Alkaloid Cyclopamine. Org. Lett 2009, 11, 2824–2827. [DOI] [PubMed] [Google Scholar]; (c) Heretsch P; Rabe S; Giannis A Synthesis of All Diastereomers of the Piperidine–Alkaloid Substructure of Cyclopamine. Org. Lett 2009, 11, 5410–5412. [DOI] [PubMed] [Google Scholar]; (d) Heretsch P; Rabe S; Giannis A A Biomimetic Approach to C-nor-D-homo Steroids. J. Am. Chem. Soc 2010, 132, 9968–9969. [DOI] [PubMed] [Google Scholar]; (e) Oblak EZ; GDayanandan N; Wright DL Tandem Metathesis Reactions of Oxabicyclo[2.2.1]heptenes: Studies on the Spirocyclic Core of Cyclopamine. Org. Lett 2011, 13, 2433–2435. [DOI] [PubMed] [Google Scholar]; (f) Zhang Z; Baubet V; Ventocilla C; Xiang C; Dahmane N; Winkler JD, Stereoselective Synthesis of F-Ring Saturated Estrone-Derived Inhibitors of Hedgehog Signaling Based on Cyclopamine. Org. Lett 2011, 13, 4786–4789. [DOI] [PMC free article] [PubMed] [Google Scholar]; (g) Isaacs AK; Xiang C; Baubet V; Dahmane N; Winkler JD, Studies Directed toward the Elucidation of the Pharmacophore of Steroid-Based Sonic Hedgehog Signaling Inhibitors. Org. Lett 2011, 13, 5140–5143. [DOI] [PMC free article] [PubMed] [Google Scholar]; (h) Taber DF; DeMatteo PW A Piperidine Chiron for the Veratrum Alkaloids. J. Org. Chem 2012, 77, 4235–4241. [DOI] [PMC free article] [PubMed] [Google Scholar]; (i) Taber DF; Berry JF Construction of the Tricyclic A-B-C Core of the Veratrum Alkaloids. J. Org. Chem 2013, 78, 8437–8441. [DOI] [PMC free article] [PubMed] [Google Scholar]; (j) Krieger J; Smeilus T; Schackow O; Giannis A Lewis Acid Mediated Nazarov Cyclization as a Convergent and Enantioselective Entry to C-nor-D-homo-Steroids. Chem. Eur. J 2017, 23, 5000–5004. [DOI] [PubMed] [Google Scholar]; (k) Zavesky BP; De Jesus Cruz P; Johnson JS Progress toward a Convergent, Asymmetric Synthesis of Jervine. Org. Lett 2020, 22, 3537–3541. [DOI] [PMC free article] [PubMed] [Google Scholar]; (l) Horwitz MA; Robins JG; Johnson JS De Novo Synthesis of the DEF-Ring Stereotriad Core of the Veratrum Alkaloids. J. Org. Chem 2020, 85, 6808–6814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9).(a) Piers E; Abeysekera B, Alkylation of enolate anions with dimethyl 3-bromo-2-ethoxypropenylphosphonate. A convergent cyclopentenone annulation method. Can. J. Chem 1982, 60, 1114–1121. [Google Scholar]; (b) Enomoto M; Morita A; Kuwahara S, Total Synthesis of the Tremorgenic Indole Diterpene Paspalinine. Angew. Chem. Int. Ed 2012, 51, 12833–12836. [DOI] [PubMed] [Google Scholar]
- 10).Iwasaki K; Wan KK; Oppedisano A; Crossley SWM; Shenvi RA, Simple, Chemoselective Hydrogenation with Thermodynamic Stereocontrol. J. Am. Chem. Soc 2014, 136, 1300–1303. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11).(a) Baker BA; Bošković ŽV; Lipshutz BH, (BDP)CuH: A “Hot” Stryker's Reagent for Use in Achiral Conjugate Reductions. Org. Lett 2008, 10, 289–292. For an example of its application in total synthesis, see: [DOI] [PubMed] [Google Scholar]; (b) Gao AX; Hamada T; Snyder SA, The Enantioselective Total Synthesis of Exochomine. Angew. Chem. Int. Ed 2016, 55, 10301–10306. [DOI] [PubMed] [Google Scholar]
- 12).Richard F; Aubert S; Katsina T; Reinalda L; Palomas D; Crespo-Otero R; Huang J; Leitch DC; Mateos C; Arseniyadis S, Enantioselective synthesis of γ-butenolides through Pd-catalysed C5-selective allylation of siloxyfurans. Nat. Synth 2022, 1, 641–648. [Google Scholar]
- 13).Krasovskiy A; Kopp F; Knochel P, Soluble Lanthanide Salts (LnCl3·2LiCl) for the Improved Addition of Organomagnesium Reagents to Carbonyl Compounds. Angew. Chem. Int. Ed 2006, 45, 497–500. [DOI] [PubMed] [Google Scholar]
- 14).(a) He A; Sutivisedsak N; Spilling CD, Stereoselective Synthesis of Cyclic Ethers via the Palladium-Catalyzed Intramolecular Addition of Alcohols to Phosphono Allylic Carbonates. Org. Lett 2009, 11, 3124–3127. For an excellent review on fully substituted carbon center formation with Tsuji-Trost reactions, see: [DOI] [PMC free article] [PubMed] [Google Scholar]; (b) Trost BM; Schultz JE, Palladium-catalyzed asymmetric allylic alkylation strategies for the synthesis of acyclic tetrasubstituted stereocenters. Synthesis 2019, 51, 1–30. [Google Scholar]
- 15).(a) Clavier H; Nolan SP, N-Heterocyclic Carbene and Phosphine Ruthenium Indenylidene Precatalysts: A Comparative Study in Olefin Metathesis. Chem. Eur. J 2007, 13, 8029–8036. For an example of its application in total synthesis, see: [DOI] [PubMed] [Google Scholar]; (b) Wang Y; Nagai T; Watanabe I; Hagiwara K; Inoue M, Total Synthesis of Euonymine and Euonyminol Octaacetate. J. Am. Chem. Soc 2021, 143, 21037–21047. [DOI] [PubMed] [Google Scholar]
- 16).Hill RR; Rychnovsky SD, Generation, Stability, and Utility of Lithium 4,4′-Di-tert-butylbiphenylide (LiDBB). J. Org. Chem 2016, 81, 10707–10714. [DOI] [PubMed] [Google Scholar]
- 17).a) Hendrickson JB Systematic synthesis design. IV. Numerical codification of construction reactions. J. Am. Chem. Soc 1975, 97, 5784–5800. [Google Scholar]; b) Gaich T; Baran PS, Aiming for the Ideal Synthesis. J. Org. Chem 2010, 75, 4657–4673. [DOI] [PubMed] [Google Scholar]; c) Peters DS; Pitts CR; McClymont KS; Stratton TP; Bi C; Baran PS, Ideality in Context: Motivations for Total Synthesis. Acc. Chem. Res 2021, 54, 605–617. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.



